Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer
2011

Creating T Cells to Fight Lymphoma

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Yin Qingsong, Zha Xianfeng, Yang Lijian, Chen Shaohua, Zhou Yubing, Wu Xiuli, Li Yangqiu

Primary Institution: Institute of Hematology, Medical College, Jinan University

Hypothesis

Can T cell receptor (TCR) gene transfer generate T cells that specifically target diffuse large B cell lymphoma (DLBCL)?

Conclusion

Specific anti-DLBCL cytotoxic T lymphocytes (CTL) can be induced by transduction of specific TCR genes to modify healthy T cells.

Supporting Evidence

  • The study successfully constructed two types of recombinant plasmids for TCR genes.
  • TCR gene-modified T cells showed specific cytotoxicity against DLBCL cell lines.
  • The transgene cassette of TCR Vβ13-IRES-TCR Vα6 was more effective than the alternative configuration.

Takeaway

Scientists are trying to make special T cells that can find and attack lymphoma cells by changing their genes.

Methodology

TCR genes were transferred into human T cells using Nucleofector™ technology, and the cytotoxicity of modified T cells was assessed using a lactate dehydrogenase release assay.

Limitations

The study used a transient expression technique, which may not provide stable long-term results.

Participant Demographics

Healthy donors (HLA-A2 positive) were used for T cell isolation.

Statistical Information

P-Value

0.014

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-8722-4-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication